Study on FabiFlu supports safety, effectiveness with no new red signals
Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India.The PMS study, commenced in July 2020, aimed to evaluate safety and efficacy of…